What is Corvus Pharmaceuticals's free cash flow yield?

Corvus Pharmaceuticals (CRVS) reported free cash flow yield of -2.9% in Q1 2026.

What is the long-term trend for Corvus Pharmaceuticals's free cash flow yield?

Over 2 years (2021 to 2025), Corvus Pharmaceuticals's free cash flow yield has grown at a -58.1% compound annual growth rate (CAGR), from -32.7% to -5.7%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Corvus Pharmaceuticals CRVS Free cash flow yield

Free cash flow yield at other companies

Eli LillyLLY

1.4%+0.9pp

Regeneron PharmaceuticalsREGN

5%+0.6pp

AbbVieABBV

5.2%+1.0pp

Avalo TherapeuticsAVTX

-63.1%-29.0pp

Cullinan Therapeutics, Inc.CGEM

-20.5%-5.1pp

Arcus BiosciencesRCUS

-18.1%—

Other financials

Income statement

See full

Operating income-$14.9M-49.9%

Net income-$13.7M-190%

EPS (diluted)-$0.15-15.4%

Balance sheet

See full

Cash & equivalents$40.1M+702%

Total debt$834.0K-27.7%

Total equity$240.7M+388%

Total assets$253.2M+326%

Cash flow

See full

Operating cash flow-$10.4M-25.5%

CapEx$91.0K+153%

Free cash flow-$10.5M-26.1%

Valuation

See full

Market cap$1.1B+259%

Enterprise value$1.06B+251%

Returns & leverage

See full

Return on equity-30.5%-12.5pp

Debt / equity0×0.0×

Current ratio19.8×+14.9×

Where this comes from

Calculated from Corvus Pharmaceuticals’s reported figures.

free cash flow/market cap=-2.9%

Based on trailing twelve months.

The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvus Pharmaceuticals's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corvus Pharmaceuticals's free cash flow yield?: Corvus Pharmaceuticals (CRVS) reported free cash flow yield of -2.9% in Q1 2026.
What is the long-term trend for Corvus Pharmaceuticals's free cash flow yield?: Over 2 years (2021 to 2025), Corvus Pharmaceuticals's free cash flow yield has grown at a -58.1% compound annual growth rate (CAGR), from -32.7% to -5.7%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.